Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.370
-0.030 (-2.14%)
Apr 29, 2025, 4:00 PM EDT - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $39.56 million as of April 30, 2025. Its market cap has increased by 353.88% in one year.
Market Cap
39.56M
Enterprise Value
40.22M
1-Year Change
353.88%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $39.56M, a decrease of -86.43%. That is a compound annual growth rate of -18.80%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |